TickerFactsScreenerDevelopers

Esperion Therapeutics, Inc. (ESPR) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: -$19.31M2011: -$30.03M2012: -$41.37M2013: $74.09M2014: $133.55M2015: $287.26M2016: $228.60M2017: $244.69M2018: $79.12M2019: $19.95M2020: -$96.13M2021: -$196.94M2022: -$323.78M2023: -$454.99M2024: -$388.72M2025: -$301.96M-$301.96M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025-$301.96M+22.3%
2024-$388.72M+14.6%
2023-$454.99M-40.5%
2022-$323.78M-64.4%
2021-$196.94M-104.9%
2020-$96.13M-581.9%
2019$19.95M-74.8%
2018$79.12M-67.7%
2017$244.69M+7.0%
2016$228.60M-20.4%
2015$287.26M+115.1%
2014$133.55M+80.3%
2013$74.09M+279.1%
2012-$41.37M-37.7%
2011-$30.03M-55.5%
2010-$19.31M—